Here's what Jim Cramer had to say about some of the stocks during the Mad Money Lightning Round:

Exact Sciences (EXAS) : "I think this is a good company and they're saving lives."

Cognizant Technology (CTSH) : "This is a terrific story. I also like DXC Technology (DXC) ."

MetLife (MET) : "This is well run. I'd like to see a pullback."

HSBC Holdings (HSBC) : "No, no, this one is too hard and too complicated. Go with JPMorgan Chase (JPM) or Citigroup (C) ."

TJX Companies (TJX) : "This one has been hurting but I think the business is good. "

Genworth Financial (GNW) : "No, we're going to stay away. I don't like balance sheet issues."

Quantenna Communications (QTNA) : "No, we have Broadcom (AVGO) . "

Stericycle (SRCL) : "No, no. This one is not working. UnitedHealth Group (UNH) if you want to be in that segment."

On Real Money, Cramer says that while he knows this rally has been amazing, as long as people are incredulous or scared, there's trillions of dollars on the sidelines that can still come in. Get more on his insights with a free trial subscription to Real Money.

Cramer and the AAP team have updates on five big names in their portfolio, including Allergan (AGN) and Broadcom (AVGO) . Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

More of What's Trending on TheStreet:

At the time of publication, Cramer's Action Alerts PLUS had a position in AGN, AVGO, C, TJX, DXC.

More from Jim Cramer

Gilead Sciences, KeyCorp, Ventas: 'Mad Money' Lightning Round

Gilead Sciences, KeyCorp, Ventas: 'Mad Money' Lightning Round

Is the Fed on Course?: Cramer's 'Mad Money' Recap (Wednesday 10/17/18)

Is the Fed on Course?: Cramer's 'Mad Money' Recap (Wednesday 10/17/18)

Jim Cramer Dives Into Cannabis and IBM Earnings

Jim Cramer Dives Into Cannabis and IBM Earnings

Wednesday Wrap-Up: The Talk of the Town Is Cannabis

Wednesday Wrap-Up: The Talk of the Town Is Cannabis

Jim Cramer: Is the Fed Right With Its Current Course of Raising Rates?

Jim Cramer: Is the Fed Right With Its Current Course of Raising Rates?